Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Shares Outstanding (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Shares Outstanding for 9 consecutive years, with $28.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding fell 3.9% to $28.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.6 million through Dec 2025, down 3.9% year-over-year, with the annual reading at $28.6 million for FY2025, 3.9% down from the prior year.
  • Shares Outstanding hit $28.6 million in Q4 2025 for Inspire Medical Systems, down from $29.1 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $30.0 million in Q3 2024 to a low of $27.2 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $28.8 million across 5 years, with a median of $29.1 million in 2023.
  • Biggest five-year swings in Shares Outstanding: increased 11.66% in 2021 and later decreased 3.9% in 2025.
  • Year by year, Shares Outstanding stood at $27.4 million in 2021, then grew by 5.81% to $29.0 million in 2022, then rose by 1.9% to $29.6 million in 2023, then increased by 0.61% to $29.7 million in 2024, then decreased by 3.9% to $28.6 million in 2025.
  • Business Quant data shows Shares Outstanding for INSP at $28.6 million in Q4 2025, $29.1 million in Q3 2025, and $29.6 million in Q2 2025.